Anzeige
Mehr »
Login
Donnerstag, 04.03.2021 Börsentäglich über 12.000 News von 657 internationalen Medien
Transformation! PepsiCo-Top-Manager übernimmt Ruder bei BevCanna
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 874929 ISIN: FR0000031577 Ticker-Symbol: V16 
Frankfurt
04.03.21
09:16 Uhr
216,00 Euro
-6,00
-2,70 %
Branche
Pharma
Aktienmarkt
CAC Mid 60
1-Jahres-Chart
VIRBAC SA Chart 1 Jahr
5-Tage-Chart
VIRBAC SA 5-Tage-Chart
RealtimeGeldBriefZeit
214,50218,0010:44

Aktuelle News zur VIRBAC Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
11.02.Virbac: Declaration of the number of shares and voting rights January 20211
VIRBAC Aktie jetzt für 0€ handeln
11.02.Virbac: Declaration of the number of shares and voting rights December 2020-
19.01.Virbac: VIRBAC:2020 annual revenue shows strong growth of +5.7% at constant exchange rates and scope (+3.2% at constant rates)347KEY FIGURESRevenue in 2020provisional €934.2 millionGrowth at constant exchange rates and scope 1 +5.7% of which companion animals +5.5% food-producing animals +6.6%Growth...
► Artikel lesen
12.01.SymbioCellTech, LLC: Virbac and SymbioCellTech Sign Exclusive Option Agreement to Develop Novel Technology for Treatment of Type 1 Diabetes in Companion Animals304SALT LAKE CITY, UT and CARROS, FRANCE / ACCESSWIRE / January 12, 2021 / SymbioCellTech, LLC (SCT), a biotechnology company in Salt Lake City, pioneering stem cell therapy for diabetes, today announced...
► Artikel lesen
04.12.20Virbac: Declaration of the number of shares and voting rights 11/20204
06.11.20Virbac: Declaration of the number of shares and voting rights October 20203
14.10.20Virbac: VIRBAC: Revenue grew +6.8% at constant exchange rates and scope at the end of September 2020 (+5.6% at constant rates) thanks to solid third quarter performance300KEY FIGURESRevenueYear-to-date September 2020€713.9 millionTotal growth+2.4%(+3.3% excl. Sentinel)Growth at constant exchange rates+5.6% Growth at constant exchange rates and scope 1+6.8% including...
► Artikel lesen
13.10.20Virbac will change its governance at its shareholders' meeting on December 15377Virbac will amend its articles of association at an extraordinary shareholders' meeting to be held in December to transform it into a company with a board of directors, the most common form...
► Artikel lesen
09.10.20Virbac: Declaration of the number of shares and voting rights Sept.20201
16.09.20Virbac: Half-yearly financial report 2020249Please find attached 2020 Half-yearly financial report of Virbac Attachment Virbac_Half-yearly financial report_2020 (https://ml-eu.globenewswire.com/Resource/Downlo...
► Artikel lesen
16.09.20Virbac: VIRBAC: Operating profit from ordinary activities up sharply for the first half of 2020 reflecting revenue resiliency and strong expenditure restraint during the Covid-19 crisis341The disposal of Sentinel on July 1, 2020 will have an impact on the accounts of the second half of the year, but has enabled the group to reduce entirely its net debt CONSOLIDATED DATA AS OF JUNE...
► Artikel lesen
08.09.20Virbac: Declaration of the number of shares and voting rights 07/20201
20.07.20Virbac: Revenue grew by +5.0% at constant exchange rates in the first half of 2020 (+4.5% excluding Sentinel), impacted by a decline in the second quarter of the year276KEY FIGURESRevenue 1st half-year 2020 - Provisional €478.3 MTotal growth +3.1%Growth at constant exchange rates +5.0% (+4.5% excl. Sentinel)Growth at constant exchange rates and scope 1 +5.0% including...
► Artikel lesen
02.07.20Virbac completes divestment of U.S. Rights to SENTINEL brands to MSD Animal Health694Virbac, today announced the successful completion of its divestment of the U.S. rights to its parasiticides for dogs: SENTINEL FLAVOR TABS and SENTINEL SPECTRUM to MSD Animal Health, a division of Merck...
► Artikel lesen
13.05.20Virbac to divest U.S. Rights to SENTINEL brands to MSD Animal Health2.353Virbac announces that it has entered into an agreement with MSD Animal Health, a division of Merck & Co., Inc., Kenilworth, N.J., USA (NYSE:MRK), to divest veterinary products currently marketed in...
► Artikel lesen
30.04.20Virbac Annual Report 2019236Virbac Annual Report 2019 Attachment Virbac_RA_EN_2019 (https://ml-eu.globenewswire.com/Resource/Download/5ed1ac58-7cb2-4309-8af9-5337dd636169)
► Artikel lesen
15.04.20Virbac: 2020 first quarter revenue rose by +14.3% at comparable exchange rates, significantly impacted by anticipatory buying4372020 first quarter revenue rose by +14.3% at comparable exchange rates, significantly impacted by anticipatory buying Key figuresRevenue1st quarter 2020 €247.7 MTotal growth +13.9%Growth at constant...
► Artikel lesen
16.03.20Virbac: 2019 operating profit from ordinary activities on the rise2952019 operating profit from ordinary activities on the rise CONSOLIDATED FIGURES AS OF DECEMBER 31in € million 20192018% change 2019/2018 Revenue from ordinary activities938.3868.9+8.0% Evolution...
► Artikel lesen
18 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1